Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07520188) titled 'C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States' on April 2.

Study Type: Observational

Primary Sponsor: UNC Lineberger Comprehensive Cancer Center

Condition: Human Immunodeficiency Virus (HIV) Human Papillomavirus (HPV) Cervical Cancer Cervical Precancer

Intervention: Behavioral: Qualitative interviews

Recruitment Status: Not recruiting

Date of First Enrollment: April 2026

Target Sample Size: 103

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07520188

Published by HT Digital Content Se...